David Warrow

1.2k total citations · 1 hit paper
8 papers, 508 citations indexed

About

David Warrow is a scholar working on Radiology, Nuclear Medicine and Imaging, Ophthalmology and Dermatology. According to data from OpenAlex, David Warrow has authored 8 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Ophthalmology and 2 papers in Dermatology. Recurrent topics in David Warrow's work include Retinal Imaging and Analysis (2 papers), Retinal Diseases and Treatments (2 papers) and Retinal and Macular Surgery (2 papers). David Warrow is often cited by papers focused on Retinal Imaging and Analysis (2 papers), Retinal Diseases and Treatments (2 papers) and Retinal and Macular Surgery (2 papers). David Warrow collaborates with scholars based in United States, Switzerland and Slovakia. David Warrow's co-authors include Quan V. Hoang, K. Bailey Freund, Daniel M. Berinstein, Michael M. Lai, Steven A. McCormick, Elizabeth A. Maher, Richard B. Rosen, Tatyana Milman, Ambika Hoguet and David Eichenbaum and has published in prestigious journals such as American Journal of Ophthalmology, Investigative Ophthalmology & Visual Science and Retina.

In The Last Decade

David Warrow

8 papers receiving 480 citations

Hit Papers

PACHYCHOROID PIGMENT EPITHELIOPATHY 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Warrow United States 5 468 373 42 36 20 8 508
Seth D. Potash United States 7 289 0.6× 191 0.5× 15 0.4× 35 1.0× 15 0.8× 11 348
D. McHugh United Kingdom 11 316 0.7× 200 0.5× 37 0.9× 30 0.8× 12 0.6× 17 330
Ji Won Lim South Korea 11 445 1.0× 300 0.8× 27 0.6× 35 1.0× 8 0.4× 21 491
J I Patel United Kingdom 7 271 0.6× 189 0.5× 21 0.5× 51 1.4× 10 0.5× 8 314
Thomas G. Chu United States 7 294 0.6× 167 0.4× 75 1.8× 13 0.4× 6 0.3× 14 336
Shérif M. El-Harazi United States 12 372 0.8× 123 0.3× 56 1.3× 20 0.6× 10 0.5× 24 450
Julián García Sánchez Spain 10 299 0.6× 269 0.7× 9 0.2× 20 0.6× 14 0.7× 36 412
Katharina Eibenberger Austria 13 411 0.9× 298 0.8× 36 0.9× 49 1.4× 2 0.1× 31 456
Oswaldo Ferreira Moura Brasil Brazil 10 370 0.8× 198 0.5× 61 1.5× 36 1.0× 6 0.3× 30 401
Gunnar M. Zoega Iceland 4 296 0.6× 327 0.9× 20 0.5× 38 1.1× 4 0.2× 6 388

Countries citing papers authored by David Warrow

Since Specialization
Citations

This map shows the geographic impact of David Warrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Warrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Warrow more than expected).

Fields of papers citing papers by David Warrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Warrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Warrow. The network helps show where David Warrow may publish in the future.

Co-authorship network of co-authors of David Warrow

This figure shows the co-authorship network connecting the top 25 collaborators of David Warrow. A scholar is included among the top collaborators of David Warrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Warrow. David Warrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Singh, Rishi P., Mark Barakat, Michael S. Ip, et al.. (2023). Efficacy and Safety of Brolucizumab for Diabetic Macular Edema. JAMA Ophthalmology. 141(12). 1152–1152. 16 indexed citations
2.
Boyer, David S., Allen Hu, David Warrow, et al.. (2023). LIGHTSITE III. Retina. 44(3). 487–497. 19 indexed citations
3.
Warrow, David, et al.. (2014). Intravitreal Ocriplasmin for Symptomatic Vitreomacular Adhesion. Investigative Ophthalmology & Visual Science. 55(13). 319–319. 2 indexed citations
4.
Warrow, David, et al.. (2014). Treatment Outcomes and Spectral-Domain Optical Coherence Tomography Findings of Eyes With Symptomatic Vitreomacular Adhesion Treated With Intravitreal Ocriplasmin. American Journal of Ophthalmology. 159(1). 20–30.e1. 39 indexed citations
5.
Yin, Dan, Andrew Huang, David Warrow, et al.. (2013). Detection of Herpes Simplex Virus Type 1 in Failed Descemet Stripping Automated Endothelial Keratoplasty Grafts. Cornea. 32(9). 1189–1192. 4 indexed citations
6.
Warrow, David, Quan V. Hoang, & K. Bailey Freund. (2013). PACHYCHOROID PIGMENT EPITHELIOPATHY. Retina. 33(8). 1659–1672. 411 indexed citations breakdown →
7.
Warrow, David, et al.. (2012). Relationship between Helicobacter Pylori and Central Serous Chorioretinopathy. Investigative Ophthalmology & Visual Science. 53(14). 5227–5227. 2 indexed citations
8.
Hoguet, Ambika, et al.. (2012). Mucin-producing Sweat Gland Carcinoma of the Eyelid: Diagnostic and Prognostic Considerations. American Journal of Ophthalmology. 155(3). 585–592.e2. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026